Eastgate Biotech Corp Stock Net Income
| ETBIDelisted Stock | USD 0 0.00 0.00% |
Eastgate Biotech Corp fundamentals help investors to digest information that contributes to Eastgate Biotech's financial success or failures. It also enables traders to predict the movement of Eastgate Stock. The fundamental analysis module provides a way to measure Eastgate Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eastgate Biotech stock.
Eastgate |
Eastgate Biotech Corp Company Net Income Analysis
Eastgate Biotech's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Eastgate Biotech Net Income | (2.98 M) |
Most of Eastgate Biotech's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eastgate Biotech Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Eastgate Biotech Corp reported net income of (2.98 Million). This is 100.87% lower than that of the Healthcare sector and significantly lower than that of the Pharmaceuticals industry. The net income for all United States stocks is 100.52% higher than that of the company.
Eastgate Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eastgate Biotech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eastgate Biotech could also be used in its relative valuation, which is a method of valuing Eastgate Biotech by comparing valuation metrics of similar companies.Eastgate Biotech is currently under evaluation in net income category among its peers.
Eastgate Fundamentals
| Operating Margin | (74.40) % | |||
| Current Valuation | 18.92 M | |||
| Shares Outstanding | 2.06 B | |||
| Price To Earning | (0.10) X | |||
| Price To Sales | 1.49 X | |||
| EBITDA | (3.55 M) | |||
| Net Income | (2.98 M) | |||
| Cash And Equivalents | 4.91 K | |||
| Total Debt | 1.67 M | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (389.48 K) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | -3039.35 | |||
| Market Capitalization | 205.75 K | |||
| Retained Earnings | (14.63 M) | |||
| Working Capital | (1.94 M) | |||
| Current Asset | 167 K | |||
| Current Liabilities | 2.11 M |
About Eastgate Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eastgate Biotech Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eastgate Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eastgate Biotech Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Eastgate Stock
If you are still planning to invest in Eastgate Biotech Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eastgate Biotech's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |